Exchange Traded Concepts LLC raised its holdings in Semler Scientific, Inc. (NASDAQ:SMLR - Free Report) by 345.8% during the 4th quarter, according to its most recent disclosure with the Securities and Exchange Commission (SEC). The institutional investor owned 61,396 shares of the company's stock after purchasing an additional 47,625 shares during the period. Exchange Traded Concepts LLC owned 0.66% of Semler Scientific worth $3,315,000 at the end of the most recent reporting period.
Several other large investors have also modified their holdings of the business. Newbridge Financial Services Group Inc. purchased a new stake in Semler Scientific in the 2nd quarter valued at approximately $34,000. Quest Partners LLC lifted its position in shares of Semler Scientific by 48.0% in the third quarter. Quest Partners LLC now owns 2,520 shares of the company's stock valued at $59,000 after acquiring an additional 817 shares in the last quarter. US Bancorp DE boosted its stake in shares of Semler Scientific by 60.8% during the third quarter. US Bancorp DE now owns 3,064 shares of the company's stock valued at $72,000 after acquiring an additional 1,158 shares during the last quarter. Sanctuary Advisors LLC purchased a new stake in Semler Scientific during the 3rd quarter worth about $104,000. Finally, Veery Capital LLC acquired a new position in Semler Scientific in the 4th quarter valued at about $324,000. 49.37% of the stock is currently owned by institutional investors and hedge funds.
Semler Scientific Price Performance
SMLR traded down $5.69 during trading on Friday, hitting $55.46. The company's stock had a trading volume of 2,298,192 shares, compared to its average volume of 379,771. Semler Scientific, Inc. has a twelve month low of $20.88 and a twelve month high of $81.56. The firm's 50 day moving average price is $60.44 and its 200-day moving average price is $40.40. The stock has a market cap of $514.11 million, a PE ratio of 27.05 and a beta of 1.18.
Semler Scientific (NASDAQ:SMLR - Get Free Report) last issued its quarterly earnings results on Monday, November 4th. The company reported $0.72 earnings per share (EPS) for the quarter, topping analysts' consensus estimates of $0.37 by $0.35. Semler Scientific had a return on equity of 20.31% and a net margin of 27.00%. The firm had revenue of $13.51 million for the quarter.
Analyst Ratings Changes
Separately, Lake Street Capital lifted their price target on shares of Semler Scientific from $40.00 to $71.00 and gave the stock a "buy" rating in a report on Friday.
Get Our Latest Stock Report on Semler Scientific
Semler Scientific Company Profile
(
Free Report)
Semler Scientific, Inc provides technology solutions to enhance the clinical effectiveness and efficiency of healthcare providers in the United States. The company's products include QuantaFlo, a four-minute in-office blood flow test that enables healthcare providers to use blood flow measurements as part of their examinations of a patient's vascular condition.
Read More
Before you consider Semler Scientific, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Semler Scientific wasn't on the list.
While Semler Scientific currently has a "Buy" rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Which stocks are likely to thrive in today's challenging market? Enter your email address and we'll send you MarketBeat's list of ten stocks that will drive in any economic environment.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.
